This inventor holds 1 USPTO granted patent. Top assignee: Ucbbiopharma Srl. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Celal Ates: Innovator in Pharmaceutical Prodrugs
Introduction
Celal Ates is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs. His work is characterized by a focus on innovative chemical compounds that have the potential to improve therapeutic outcomes.
Latest Patents
Celal Ates holds a patent for a prodrug of 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone. This invention is represented by formula (II) and aims to enhance the efficacy of the original compound.
Career Highlights
Celal Ates is currently associated with Ucbbiopharma Srl, where he continues to advance his research and development efforts. His career is marked by a commitment to innovation in drug formulation and delivery.
Collaborations
He has collaborated with notable colleagues, including Ali Ates and Laurent Provins, to further enhance the impact of his work in the pharmaceutical industry.
Conclusion
Celal Ates is a distinguished inventor whose contributions to the field of pharmaceuticals are noteworthy. His innovative approach to prodrugs exemplifies the potential for advancements in drug therapy.